Hinge Bio has expanded its leadership bench and unveiled peer‑reviewed preclinical data for HB2198, a dual‑Fc, anti‑CD19/CD20 bispecific antibody...

Japan’s Ministry of Health, Labour and Welfare has granted orphan drug designation to mosliciguat, Pulmovant’s once-daily, inhaled soluble guanylate...

Syndax Pharmaceuticals has granted inducement stock options to purchase 167,400 shares of common stock to 11 new employees under...

Adarx Pharmaceuticals will present at the Morgan Stanley Global Healthcare Conference on September 9, 2025, with its chief executive...

Biogen’s investigational new drug application for BIIB142, an oral degrader of IRAK4 for autoimmune diseases, has been accepted by...

Mesoblast has secured an option to raise to $50 million via unsecured convertible notes from SurgCenter principals and two...

Radiance Biopharma has secured an exclusive ex-China license to develop and commercialize RB-601 (KY-0301), a bispecific nanobody antibody-drug conjugate...

Arcutis has submitted a supplemental new drug application to the FDA seeking to expand Zoryve (roflumilast) cream 0.3% for...

BioNTX has named its 2025 Rising Stars—eight early- and growth-stage companies spanning diagnostics, therapeutics, delivery platforms, and surgical technologies—to...

IP Australia has granted patent number 2020271839 to Columbia University for the prophylactic use of serotonin 4 (5-HT4) receptor...